FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Implant, Anti-Gastroesophageal Reflux

PMA: P100049 · Supplement: S041 · Decision Jan 16, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
Implant, Anti-Gastroesophageal Reflux
Trade Name
LINX Reflux Management System
PMA Number
P100049
Supplement Number
S041
Device Class
FDA Class 3
Product Code
LEI
Generic Name
IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
Medical Specialty
Unknown
Advisory Committee
Gastroenterology, Urology
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
January 16, 2026
Date Received
December 17, 2025
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

replacement of laser welder for the manufacturing processes

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LEI Implant, Anti-Gastroesophageal Reflux